News | Patient Monitors | May 26, 2016

Corsens Medical Ltd. Files 510(k) Pre-Marketing Notification for Corsens Cardiac Monitor

Monitor is intended to detect heart contractility parameters required for continuous heart function monitoring

Corsens Cardiac Monitor, FDA 510k pre-market notification

May 26, 2016 — Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the U.S. Food and Drug Administration (FDA) for its Corsens Cardiac Monitor.

The company is seeking the following indications statement for the Corsens Cardiac Monitor: " “Corsens records vibrational waveforms produced by the heart contractions and transmitted to the chest wall. Corsens may be used as a tool to measure the timing of part of the events in the cardiac cycle.” The Corsens Cardiac Monitor is designed to detect cardiac contractility parameters via a series of acoustic, accelerometers and cardiac rhythm non-invasive sensors arrayed on the patient's chest.

Alon Tomas Marmor, M.D., previously clinical professor, faculty of medicine, Bar-Ilan University, Israel, commented, "Acute myocardial infarction (MI) remains a leading cause of morbidity and mortality worldwide. Only 15-20 percent of the patients who suspect that they are having an MI and present to an emergency department have pain of cardiac origin. There is an unmet need for a device that can provide a non-invasive and quick assessment of cardiac ischemia. The Corsens Cardiac Monitor has the potential to detect myocardial contractility changes which can direct clinical management of cardiac ischemia."

For more information: www.microdel.co.il/cardiac.asp


Related Content

News | Patient Monitors

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
Feature | Patient Monitors | By Amit Shah, MD, MSCR

I work at Emory University in a multidisciplinary group that is employing medical technologies to improve our ...

Home May 05, 2022
Home
News | Patient Monitors
March 11, 2022 – Bittium will join the 65th Congress of the German Society for Clinical Neurophysiology and Functional ...
Home March 11, 2022
Home
News | Patient Monitors

June 18, 2019 – New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense ...

Home June 18, 2019
Home
News | Patient Monitors

August 16, 2018 — Lexington Biosciences Inc. recently announced the completion of the initial HeartSentry study ...

Home August 16, 2018
Home
Technology | Patient Monitors

May 16, 2018 — Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care ...

Home May 16, 2018
Home
News | Patient Monitors

March 9, 2018 — Philips recently announced the integration of its IntelliVue Guardian with automated Early Warning ...

Home March 09, 2018
Home
News | Patient Monitors

March 30, 2017 — Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System ...

Home March 30, 2017
Home
Technology | Patient Monitors

December 8, 2016 — Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k ...

Home December 08, 2016
Home
Technology | Patient Monitors

February 11, 2016 — Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression ...

Home February 11, 2016
Home
Subscribe Now